Millennium Management’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-57,740
| Closed | -$165K | – | 6058 |
|
|
2025
Q3 | $165K | Buy |
57,740
+22,080
| +62% | +$57.2K | ﹤0.01% | 5599 |
|
|
2025
Q2 | $53.8K | Sell |
35,660
-68,194
| -66% | -$98.5K | ﹤0.01% | 5608 |
|
|
2025
Q1 | $129K | Sell |
103,854
-430,697
| -81% | -$638K | ﹤0.01% | 5394 |
|
|
2024
Q4 | $962K | Buy |
+534,551
| New | +$997K | ﹤0.01% | 4234 |
|
|
2023
Q4 | – | Sell |
-1,095,966
| Closed | -$1.73M | – | 6137 |
|
|
2023
Q3 | $1.73M | Sell |
1,095,966
-71,675
| -6% | -$140K | ﹤0.01% | 3695 |
|
|
2023
Q2 | $2.3M | Sell |
1,167,641
-12,418
| -1% | -$23.8K | ﹤0.01% | 3352 |
|
|
2023
Q1 | $2.28M | Buy |
1,180,059
+500,093
| +74% | +$1.25M | ﹤0.01% | 3315 |
|
|
2022
Q4 | $1.43M | Buy |
679,966
+106,125
| +18% | +$240K | ﹤0.01% | 3840 |
|
|
2022
Q3 | $1.31M | Buy |
573,841
+120,900
| +27% | +$366K | ﹤0.01% | 4110 |
|
|
2022
Q2 | $1.28M | Buy |
452,941
+50,039
| +12% | +$176K | ﹤0.01% | 4147 |
|
|
2022
Q1 | $1.83M | Buy |
402,902
+278,987
| +225% | +$1.54M | ﹤0.01% | 3973 |
|
|
2021
Q4 | $1.01M | Sell |
123,915
-62,225
| -33% | -$612K | ﹤0.01% | 4401 |
|
|
2021
Q3 | $2.35M | Buy |
186,140
+119,872
| +181% | +$1.66M | ﹤0.01% | 3722 |
|
|
2021
Q2 | $1.02M | Buy |
66,268
+35,781
| +117% | +$602K | ﹤0.01% | 4640 |
|
|
2021
Q1 | $616K | Buy |
+30,487
| New | +$754K | ﹤0.01% | 4647 |
|
|
2020
Q4 | – | Sell |
-293,843
| Closed | -$6.59M | – | 5228 |
|
|
2020
Q3 | $5.44K | Sell |
293,843
-18,200
| -6% | -$323K | 0.01% | 1761 |
|
|
2020
Q2 | $5.55M | Buy |
312,043
+71,777
| +30% | +$1.09M | 0.01% | 1672 |
|
|
2020
Q1 | $2.21M | Sell |
240,266
-76,012
| -24% | -$1.13M | 0.01% | 1945 |
|
|
2019
Q4 | $5.42M | Sell |
316,278
-7,938
| -2% | -$106K | 0.01% | 1865 |
|
|
2019
Q3 | $3.37M | Buy |
324,216
+145,484
| +81% | +$1.96M | 0.01% | 2092 |
|
|
2019
Q2 | $2.79M | Buy |
178,732
+63,743
| +55% | +$1.14M | ﹤0.01% | 2204 |
|
|
2019
Q1 | $2.11M | Buy |
114,989
+33,942
| +42% | +$602K | ﹤0.01% | 2372 |
|
|
2018
Q4 | $1.35M | Sell |
81,047
-37,304
| -32% | -$865K | ﹤0.01% | 2432 |
|
|
2018
Q3 | $3.34M | Sell |
118,351
-27,212
| -19% | -$782K | ﹤0.01% | 2079 |
|
|
2018
Q2 | $4.12M | Buy |
145,563
+100,515
| +223% | +$2.99M | 0.01% | 1936 |
|
|
2018
Q1 | $1.42M | Sell |
45,048
-59,242
| -57% | -$1.87M | ﹤0.01% | 2518 |
|
|
2017
Q4 | $3.04M | Buy |
104,290
+97,128
| +1,356% | +$2.65M | ﹤0.01% | 2020 |
|
|
2017
Q3 | $204K | Sell |
7,162
-35,438
| -83% | -$916K | ﹤0.01% | 3238 |
|
|
2017
Q2 | $1.1M | Buy |
42,600
+18,442
| +76% | +$440K | ﹤0.01% | 2401 |
|
|
2017
Q1 | $580K | Sell |
24,158
-46,545
| -66% | -$978K | ﹤0.01% | 2735 |
|
|
2016
Q4 | $1.2M | Sell |
70,703
-111,332
| -61% | -$2.06M | ﹤0.01% | 2146 |
|
|
2016
Q3 | $4.38M | Buy |
182,035
+7,142
| +4% | +$187K | 0.01% | 1417 |
|
|
2016
Q2 | $4.65M | Buy |
174,893
+147,239
| +532% | +$4.32M | 0.01% | 1311 |
|
|
2016
Q1 | $760K | Sell |
27,654
-159,761
| -85% | -$3.85M | ﹤0.01% | 2318 |
|
|
2015
Q4 | $5.82M | Buy |
187,415
+171,776
| +1,098% | +$5.21M | 0.01% | 1262 |
|
|
2015
Q3 | $412K | Sell |
15,639
-72,575
| -82% | -$2.43M | ﹤0.01% | 2757 |
|
|
2015
Q2 | $3.18M | Buy |
88,214
+55,019
| +166% | +$1.93M | 0.01% | 1655 |
|
|
2015
Q1 | $1.15M | Buy |
+33,195
| New | +$1.2M | ﹤0.01% | 2250 |
|
Other funds holding CLLS
BGI
LFCM
NAMI
Millennium Management's CLLS Position: Q4 2025 in Review
Millennium Management sold out of Cellectis (CLLS) in Q4 2025, closing a stake of 57,740 shares — an estimated $165K sold.
Millennium Management first reported a position in CLLS in Q1 2015 and held it in 38 quarters. The position peaked at $5.82M in Q4 2015. 34 funds tracked by Wall St. Rank hold CLLS as of Q4 2025.
- Millennium Management reported no remaining Cellectis position as of Q4 2025 after selling out during the quarter.
- Millennium Management sold 57,740 Cellectis shares in Q4 2025, an estimated $165K.
- Millennium Management first reported a position in Cellectis in Q1 2015 and held it in 38 quarters.
- Millennium Management's Cellectis position peaked at $5.82M in Q4 2015.
- 34 funds tracked by Wall St. Rank held Cellectis as of Q4 2025.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.